FGFR3, HRAS and KRAS, along with known oncogene TP53, are typical biomarkers for bladder cancer associated with relevant pathways, and are discovered by EntCDP when K = 4 (Table S1.1 in S1 Data). The gene discussed is KRAS; the disease is urinary bladder cancer.